College of Medicine, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Kingdom of Saudi Arabia. E-mail:
Neurosciences (Riyadh). 2020 Oct;25(5):406-411. doi: 10.17712/nsj.2020.5.20200090.
Patients with isolated neurosarcoidosis (NS) can present with neurological symptoms that mimic other neurologic conditions, such as multiple sclerosis (MS). In this article, we present a case of 25-year-old man with a transverse myelitis. Magnetic resonance imaging (MRI) of the brain and spine showed several, periventricular, infratentorial, and spinal cord white matter lesions. He was diagnosed with MS and was started on fingolimod, which did not result in any improvement. Follow-up brain and spine MRI showed a longitudinally extensive lesion with leptomeningeal enhancement. Leptomeningeal and cerebellar biopsy showed non-necrotizing granulomas consistent with neurosarcoidosis. Fingolimod was discontinued. The patient was treated with oral prednisone and infliximab, which ceased the progression of the disease and allowed for slow improvement. Incorrectly diagnosing NS with MS or vice-versa, not only deprives patients of beneficial therapy, but also potentially exposes them to therapies that may be harmful.
孤立性神经结节病(NS)患者可出现类似多发性硬化症(MS)等其他神经系统疾病的神经症状。本文报道了 1 例 25 岁男性横断性脊髓炎患者。头颅和脊柱磁共振成像(MRI)显示多个脑室周围、颅后窝和脊髓白质病变。他被诊断为 MS,并开始服用芬戈莫德,但未见任何改善。随访脑和脊柱 MRI 显示长节段病变伴软脑膜增强。软脑膜和小脑活检显示非坏死性肉芽肿,符合神经结节病。停用芬戈莫德。患者接受口服泼尼松和英夫利昔单抗治疗,病情停止进展并逐渐改善。错误地将 NS 诊断为 MS 或反之,不仅使患者失去了有益的治疗,还可能使他们暴露于潜在有害的治疗中。